Novonesis sinks on margin miss, FX drag after Q2 results

** Shares in Danish biotechnology company Novonesis NSIS_B drop 6.8% to hit a more than four-month low

** Company posted its Q2 print, with analysts pointing at an earnings miss on margins, FX headwinds

** J.P. Morgan says earnings were pressured by tariffs, FX and costs, but sees the weakness as a buying opportunity

** Jefferies also notes margin pressure and adds Household Care division lagged, while Agriculture and Human Health were stronger

** The company reiterated its FY25 adj. EBITDA margin guidance of 37%-38% and nudged up its organic sales growth outlook to 6-8% (previously 5-8%)

** Stock pares earlier losses of as much as 7.8%, wiping 11.8 billion Danish crowns off its market value, now at 161.9 bln crowns